Monday, March 8, 2021

SBI Life Insurance Company Ltd showed impressive Business growth in Feb-2021 & its Valuations

Private insurers has witnessed  their new business premiums (NBP)  growing by 16 per cent in February to Rs 9,504.64 crore, compared with Rs 8,128.51 crore in the same period a year earlier. NBP is the premium acquired from new policies for a particular year.

Among private players, SBI Life showed impressive growth of more than 60 per cent, HDFC Life’s NBP grew by 20 per cent, and Max Life also had an impressive growth of above 30 per cent. But, ICICI Prudential’s NBP for February de-grew by 19 per cent.

We have factored the SBI Life’s earning for the FY2021,FY2022 & FY2023 and arrived at the Valuations X3.75; X3.02 & X2.42 , while it is now trading at X4.60 of its Valuation (Last 4Q Earnings), which indicates that SBI Life is running out of its Valuations parameter, though it is growing at rate of 53%.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #

Data Source NSE Website | Screener.In  | Capital Line Money Control |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.


The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive